ACM
IOVA icon

Aquatic Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Aquatic Capital Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$165K Buy
+46,955
New +$150K ﹤0.01% 1023
2024
Q4 		– Sell
-35,200
Closed -$331K – 1467
2024
Q3 		$331K Buy
+35,200
New +$333K 0.01% 729
2024
Q2 		– Sell
-21,900
Closed -$325K – 1408
2024
Q1 		$325K Buy
+21,900
New +$255K 0.01% 651
2023
Q2 		– Sell
-10,500
Closed -$64K – 1535
2023
Q1 		$64K Buy
+10,500
New +$72.4K ﹤0.01% 838
2022
Q4 		– Sell
-68,000
Closed -$651K – 1585
2022
Q3 		$651K Buy
68,000
+57,600
+554% +$664K 0.06% 349
2022
Q2 		$115K Buy
10,400
+9,900
+1,980% +$130K 0.04% 453
2022
Q1 		$8K Buy
+500
New +$7.73K 0.01% 725

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return